NEW YORK, Sept. 18 — Bruker Daltonics has said that prior to the terrorist attacks here and in Washington last week it had been awarded a $10 million US Department of Defense contract to supply ion trap mass spectrometers for chemical and biological defense. The company said it expects revenues from the contract to be generated over five quarters from 2002 to 2003. 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.